Health

Results: 7597-7608 of 8678

Novotech Executive Team at J.P. Morgan Healthcare Conference: Global CRO Designed for Biotechs Across 25 Regions

PR Newswire associated0

Medison Pharma Announces Agreement with Regeneron Pharmaceuticals to Commercialize Libtayo® (cemiplimab) in Multiple Countries

Dr. William Pao has joined Alentis Therapeutics' Board of Directors as an independent member. (Photo: Alentis Therapeutics)

William Pao Joins Alentis Therapeutics as Independent Board Member

Business Wire logo

Biotech companies to increase R&D spend but highlight complexity of clinical trials - ICON

iTeos Announces 2024 Strategic Priorities and Anticipated Milestones

OKYO Pharma Announces OK-101 Successfully Achieved Statistical Significance for Both Sign and Symptom Endpoints in its First-in-Human Phase 2 Trial of OK-101 in Patients with Dry Eye Disease

Tiziana Life Sciences Announces Updated Clinical and PET Scan Findings for Intranasal Foralumab in Two New Multiple Sclerosis Patients

Diamyd Medical gains market research findings to guide U.S. commercial strategy

Inotrem Successfully Reaches Agreement with the FDA for a Phase 3 Registration Trial for Nangibotide in Septic Shock

Calliditas Therapeutics provides business update ahead of JP Morgan conference

Shanghai Argo Announces Multi-Program RNAi Licenses and Strategic Collaborations with Novartis

Calliditas Therapeutics appoints Maria Törnsén as President North America